PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,596 | -33.6% | 19,434 | -46.2% | 0.00% | 0.0% |
Q2 2023 | $41,546 | -68.3% | 36,127 | -41.8% | 0.00% | -80.0% |
Q3 2022 | $131,000 | -84.2% | 62,082 | -90.0% | 0.01% | -85.3% |
Q2 2022 | $830,000 | -18.5% | 619,429 | +28.2% | 0.03% | -2.9% |
Q1 2022 | $1,019,000 | +1467.7% | 483,223 | +2657.2% | 0.04% | +1066.7% |
Q4 2021 | $65,000 | -97.0% | 17,526 | -94.3% | 0.00% | -96.8% |
Q1 2021 | $2,132,000 | – | 309,467 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
EMFO, LLC | 425,000 | $603,500 | 0.57% |
Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
First Washington CORP | 646,575 | $918,137 | 0.37% |
Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |